Saxagliptin Tablet
Regulated Product — Business License RequiredB2B and export product information for licensed and authorized business customers. Contact our team regarding bulk supply, documentation, and applicable commercial, import, and export requirements. This page is not a storefront and no purchasing, checkout, or pricing is offered here.
Product Overview
Saxagliptin Tablet contains saxagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor. Its labelling describes it as a treatment for adults with type 2 diabetes mellitus, used alongside diet and exercise to improve blood sugar control, and described as helping the body release more insulin and reduce sugar output from the liver after meals.
Product Information
The following description reflects information associated with saxagliptin and this product’s labelling. It has not been independently clinically verified by SDO Pharma and is provided for business and product-identification purposes only. It is not medical advice and does not replace the manufacturer’s official prescribing information.
Described Uses
- Described for improving blood sugar control in adults with type 2 diabetes mellitus, together with diet and exercise
- Described as used alone or in combination with other antidiabetic medicines such as metformin, sulfonylureas or insulin
- Not for type 1 diabetes or diabetic ketoacidosis, per manufacturer guidance
Described Dosage & Administration
- Taken by mouth once daily, at about the same time each day, as prescribed
- Tablets are swallowed whole — not split or chewed
- The medicine should not be stopped or changed without consulting the prescriber
Described Side Effects
Commonly described side effects include:
- Upper respiratory tract infection
- Urinary tract infection
- Headache
- Described as possibly causing joint pain, pancreatitis, or hypersensitivity reactions
- Low blood sugar is described as more likely when combined with insulin or a sulfonylurea
Any severe, persistent, or unexpected reaction requires prompt medical attention.
Precautions
- Kidney function is described as needing checks, with dose adjustment in reduced kidney function
- Severe, persistent abdominal pain should be reported promptly (described as a possible sign of pancreatitis)
- Symptoms such as breathlessness or swelling should be reported (heart failure has been reported in some patients)
- Pregnancy, planned pregnancy or breastfeeding should be discussed with the prescriber
This summary is provided for informational purposes only and does not replace the manufacturer’s official product labelling or professional medical advice.
B2B, Import & Export Enquiries
SDO Pharma supports business enquiries for pharmaceutical products, including bulk and export supply, subject to applicable licensing, regulatory, import, and export requirements. Requirements vary according to the destination market and the nature of the transaction.
We do not claim that this product is available for import into every country, and we do not claim FDA, UAE, EU, or other specific regulatory approval unless independently verified. Applicable documentation — including a valid Drug License, tax registration, and Importer Exporter Code (IEC) where relevant — is discussed directly with our team as part of the enquiry process. This is a regulated / prescription-status product supplied only to licensed and authorized business customers; SDO Pharma does not sell it directly to individual patients or consumers. See our Regulated Products Policy.
Request Product Information
Interested in this product for your business? Submit your enquiry and our team will contact you regarding bulk supply, documentation, and applicable requirements.
Frequently Asked Questions
Its labelling describes it as a DPP-4 inhibitor that helps the body release more insulin and lower glucose production after meals, improving blood sugar control in type 2 diabetes. SDO Pharma has not independently verified these claims.
Per its labelling, saxagliptin is intended for type 2 diabetes only and is not for type 1 diabetes or diabetic ketoacidosis.
Licensed and authorized business customers can submit the product enquiry form above or contact our team directly. Product availability, documentation, and supply arrangements are confirmed per enquiry.
Availability depends on the destination market’s regulatory requirements and cannot be confirmed without a direct enquiry. See our B2B, Import & Export Enquiries section above.
Related Product Categories
SDO Pharma works across several pharmaceutical and healthcare product categories for business customers.